Lipid Rafts Play a Crucial Role in Protein Interactions and Intracellular Signaling Involved in Neuronal Preservation against Alzheimer's Disease

Lipids and Cellular Membranes in Amyloid Diseases

Volumn , Issue , 2011, Pages 159-175

  Marin, Raquel ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Alzheimer's disease; Amyloid toxicity; Intracellular signaling; Lipid rafts; Neuronal preservation; Protein interactions

Indexed keywords

EID: 79959869441     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527634323.ch7     Document Type: Chapter

References (104)

1. Gallagher, M. (2003) Aging and hippocampal/cortical circuits in rodents. Alzheimer Dis. Assoc. Disord., 17, S45-S47.
2. Lisanti, M.P., Scherer, P.E., Tang, Z., and Sargiacomo, M. (1994) Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell Biol, 4 (7), 231-235.
3. Tsui-Pierchala, B., Encinas, M., Milbrandt, J., and Jonson, E.M. (2002) Lipid rafts in neuronal signaling and function. Trends Neurosci., 25 (8), 412-417.
4. Ma, D.W. (2007) Lipid mediators in membrane rafts are important determinants of human health and disease.Appl. Physiol.Nutr.Metab., 32 (3), 341-350.
5. Lingwood, D. and Simons, K. (2010) Lipid rafts as a membrane-organizing principle. Science, 327, 46-50.
6. Robinson, P.J. (1997) Signal transduction via GPI-anchored membrane proteins. Adv. Exp.Med. Biol., 419, 365-370.
7. Jones, D.R. and Varela-Nieto, I. (1998) The role of glycosylphosphatidylinositol in signal transduction. Int. J. Biochem. Cell Biol., 30 (3), 313-326.
8. Chesebro, B., Trifilo, M., Race, R., Meade-White, K., Teng, C., LaCasse, R. et al. (2005) Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science, 308 (5727), 1435-1439.
9. Taylor, D.R. and Hooper, N.M. (2007) Role of lipid rafts in the processing of the pathogenic prion and Alzheimer's amyloid-beta proteins. Semin. Cell Dev. Biol., 18 (5), 638-648.
10. c association with lipid rafts in the early secretory pathway stabilizes its cellular conformation. Mol. Biol. Cell, 15, 4031-4042.
11. Mattei, V., Garofalo, T., Misasi, R., Cifcella, A., Manganelli, V., Lucania, G., Pavan, A., and Sorice, M. (2004) Prion protein is a component of the multimolecular signaling complex involved in T cell activation. FEBS Lett., 560, 14-18.
12. Russelakis-Carneiro, M., Hetz, C., Maundrell, K., and Soto, C. (2004) Prion replication alters the distribution of synaptophysin and caveolin 1 in neuronal lipid rafts. Am. J. Pathol., 165 (5), 1839-1848.
13. Sato, I., Obata, Y., Kasahara, K., Nakayama, Y., Fukumoto, Y., Yamasaki, T., Yokohama, K.K., Saito, T., and Yamaguchi, N. (2009) Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain. J. Cell Sci., 122 (7), 965-975.
14. Lee, H., Woodman, S.E., Engelman, J.A., Volonte, D., Galbiati, F., Kaufman, H.L., Lublin, D.M., and Lisanti, M.P. (2001) Palmitoylation of caveolin-1 at a single site (Cys-156) controls its coupling to the c-Src tyrosine kinase. J. Biol. Chem., 276 (37), 35150-35158.
15. Marino, M. and Ascenzi, P. (2006) Steroid hormone rapid signaling: the pivotal role of S-palmitoylation. IUBMB Life, 58 (12), 716-719.
16. Pedram, A., Razandi, M., Sainson, R.C., Kim, J.K., Hughes, C.C., and Levin, E.R. (2007) A conserved mechanism for steroid receptor translocation to the plasma membrane. J. Biol. Chem., 282 (31), 22278-22288.
17. Murakami, Y., Siripanyapinyo, U., Hong, Y., Kang, J.Y., Ishihara, S., Nakakuma, H., Maeda, Y., and Kinoshita, T. (2003) PIGW is critical for inositol acylation but not for flipping of glycosylphosphatidylinositol-anchor. Mol. Biol. Cell, 14, 4285-4295.
18. Morrow, I.C., Rea, S., Martin, S., Prior, I.A., Prohaska, B., Hancock, J.F., James, D.E., and Parton, R.G. (2002) Flotillin-1/Reggie-2 traffics to surface raft domains via a novel Golgi-independent pathway. J. Biol. Chem., 277 (50), 48834-48841.
19. Salzer, U. and Prohaska, R. (2001) Stomatin, flotillin-1 and flotillin-2 are major integral proteins of erythrocyte lipid rafts. Blood, 97, 1141-1143.
20. Parton, R.G. (2003) Caveolae-form ultrastructure to molecular mechanisms. Nat. Rev. Mol. Cell Biol., 4, 162-167.
21. Langhorst, M.F., Reuter, A., and Stuermer, C.A.O. (2005) Scaffolding microdomains and beyond: the function of reggie/flotillin proteins. Cell. Mol. Life Sci., 62, 2228-2240.
22. Cheong, K.H., Zacchetti, D., Schneeberger, E.E., and Simons, K. (1999) VIP17/MAL, a lipid-raft associated protein, is involved in apical transport in MDCK cells. Proc. Natl. Acad. Sci. USA, 96, 6241-6248.
23. Eckert, G.P. and Müller, W.E. (2009) Presenilin 1 modifies lipid raft composition of neuronal membranes. Biochem. Biophys. Res. Commun., 382 (4), 673-677.
24. Couet, J., Li, S., Okamoto, T., Ikezu, T., and Lisanti, M.P. (1997) Identification of peptide and protein ligands for the caveolae-associated proteins. J. Biol. Chem., 272, 6525-6533.
25. Arcaro, A., Aubert, M., Espinosa del Hierro, M.E., Khanzada, U.K., Angelidou, S., Tetely, T.D., Bittermann, A.G., Frame, M.C., and Seckl, M.J. (2007) Critical role for lipid raft-associated Src kinases in activation of PI3K-Akt signalling. Cell Signal., 19, 1081-1092.
26. Boulware, M.I., Kordasiewicz, J., and Mermelstein, P.G. (2007) Caveolin proteins are essential for distinct effects of membrane estrogen receptors in neurons. J. Neurosci., 27 (37), 9941-9950.
27. Toran-Allerand, C.D. (2004) Minireview: a plethora of estrogen receptors in the brain: where will it end? Endocrinology, 145, 1069-1074.
28. Luoma, J.I., Boulware, M.I., and Mermelstein, P.G. (2008) Caveolin proteins and estrogen signalling in the brain. Mol. Cell. Endocrinol., 290 (1-2), 8-13.
29. Ehehalt, R., Keller, P., Haass, C., Thiele, C., and Simons, K. (2003) Amyloidogenic processing of the Alzheimer betaamyloid precursor protein depends on lipid rafts. J. Cell Biol., 160 (1), 113-123.
30. Kang, M.J., Chung, Y.H., Hwang, Ch., Murata, M., Fujimoto, T., Mook-Jung, I.H., Cha, Ch.I., and Park, W.Y. (2006) Caveolin-1 upregulation in senescent neurons alters amyloid precursor protein processing. Exp. Mol. Med, 38 (2), 126-133.
31. Gaudreault, S.B., Dea, D., and Poirier, J. (2004) Increased caveolin-1 expression in Alzheimer's disease brain. Neurobiol. Aging, 25, 753-759.
32. Langhorst, M.F., Jaeger, F.A., Mueller, S., Hartman, L.S., Luxenhofer, G., and Stuermer, C.A.O. (2008) Reggies/flotillins regulate cytoskeletal remodelling during neuronal differentiation via CAP/ponsin and Rho GTPases. Eur. J. Cell Biol., 87, 921-931.
33. Kokubo, H., Lemere, C.A., and Yamaguchi, H. (2000) Localization of flotillins inhuman brain and their accumulation with the progression of Alzheimer's disease pathology. Neurosci. Lett., 290, 93-96.
34. Encinas, M., Tansey, M.G., Tsui-Pierchala, B.A., Comella, J.X., Milbrandt, J., and Johnson, E.M. (2001) c-Src is required for glial cell line-derived neurotrophic factor (GDNF) family ligand-mediated neuronal survival via a phosphatidylinositol-3 kinase (PI-3K)-dependent pathway. J. Neurosci., 21 (5), 1464-1472.
35. Limpert, A.S., Karlo, J.C., and Landreth, G.E. (2007) Nerve growth factor stimulates the concentration of TrkA within lipid rafts and extracellular signalregulated kinase activation through c-Cbl-associated protein. Mol. Cell Biol., 27 (16), 5686-5698.
36. Yamamoto, M., Toya, Y., Schewencke, C., Lisanti, M.P., Myers, M.G., and Ishikawa, Y. (1998) Caveolin is an activator of insulin receptor signalling. J. Biol. Chem., 273, 26962-26968.
37. Liu, J., Oh, P., Horner, T., Rogers, R.A., and Schnitzer, J.E. (1997) Organized endothelial cell surface signal transduction in caveolae distinct from glycosylphosphatidylinositol-anchored protein microdomains. J. Biol. Chem., 272 (11), 7211-7222.
38. Martens, J.R., Navarro-Polanco, R., Coppock, E.A., Nishiyama, A., Parshley, L., Grobaski, T.D., and Tamkun, M.M. (2000) Differential targeting of shakerlike potassium channels to lipid rafts. J. Biol. Chem., 275, 7443-7446.
39. Stetzkowski-Marden, F., Recouvreur, M., Camus, G., Cartaud, A., Marchand, S., and Cartaud, J. (2006) Rafts are required for acetylcholine receptor clustering. J. Mol. Neurosci., 30 (1-2), 37-38.
40. Becher, A., White, J.H., and McIlhinney, R.A. (2001) The c-aminobutyric acid receptor B, but not the metabotropic glutamate receptor type-1, associates with lipid rafts in the rat cerebellum. J. Neurochem., 79, 787-795.
41. Marin, R., Ramirez, C.M., Gonzalez, M., Gonzalez-Muñoz, E., Zorzano, A., Camps, M., Alonso, R., and Diaz, M. (2007) Voltage-dependent anion channel (VDAC) participates in amyloid betainduced toxicity and interacts with plasma membrane estrogen receptor alpha in septal and hippocampal neurons. Mol. Membr. Biol., 24 (2), 148-160.
42. Ramirez, C.M., Gonzalez, M., Diaz, M., Alonso, R., Ferrer, I., Santere, G., Puig, B., Meyer, G., and Marin, R. (2009)VDAC and ERα interaction in caveolae from human cortex is altered in Alzheimer's disease. Mol. Cell. Neurosci., 42, 172-183.
43. Maggi, A., Ciana, P., Belcredito, S., and Vegeto, E. (2004) Estrogens in the nervous system: mechanisms and nonreproductive functions. Annu. Rev. Physiol., 66, 291-313.
44. Suzuki, S., Brown, C.M., and Wise, P.M. (2006) Mechanisms of neuroprotection by estrogen. Endocrine, 29, 209-215.
45. Garcia-Segura, L.M., Azcoitia, I., and DonCarlos, L.L. (2001) Neuroprotection by estradiol. Prog. Neurobiol., 63, 29-60.
46. Woolley, C.S. (2007) Acute effects of estrogen on neuronal physiology. Annu. Rev. Pharmacol. Toxicol., 47, 657-680.
47. Rissman, E.F. (2008) Roles of oestrogen receptors alpha and beta in behavioural neuroendocrinology: beyond Ying/Yang. J. Neuroendocrinol., 20 (6), 873-879.
48. Nadal, A., Diaz, M., and Valverde, M.A. (2001) The estrogen trinity: membrane, cytosolic and nuclear effects. News Physiol. Sci., 16, 251-255.
49. Kim, H., Bang, O.Y., Jun, M.W., Ha, S.D., Hong, H.S., Huh, K., Kim, S.U., and Moo-Jung, I. (2001) Neuroprotective effects of estrogen against beta-amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells. Neurosci. Lett., 302, 58-62.
50. Marin, R., Guerra, B., Hernandez-Jimenez, J.G., Kang, X.L., Fraser, J.D., Lopez, F.J., and Alonso, R. (2003) Estradiol prevents amyloid-β peptideinduced cell death in a cholinergic cell line via modulation of a classical estrogen receptor. Neuroscience, 121, 917-926.
51. Vasudevan, N. and Pfaff, D.W. (2008) Non-genomic actions of estrogens and their interaction with genomic actions in the brain. Front. Neuroendocrinol., 29, 238-257.
52. Watson, C.S. and Gametchu, B. (1999) Membrane-initiated steroid actions and the proteins that mediate them. Proc. Soc. Exp. Biol. Med., 22, 9-19.
53. Marin, R., Guerra, B., Alonso, M., Ramirez, C.M., and Diaz, M. (2005) Estrogen activates classical and alternative mechanisms to orchestrate neuroprotection. Curr. Neurovasc. Res., 2, 287-301.
54. Revankar, C.M., Cimino, D.F., Sklar, L.A., Arterburn, J.B., and Prossnitz, E.R. (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science, 307, 1625-1630.
55. Brailiou, E., Dun, S.L., Brailou, G.C., Mizou, K., Sklar, L.A., Oprea, T.I., Prossnitz, E.R., and Dun, N.J. (2007) Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. J. Endocrinol., 193, 311-321.
56. Toran-Allerand, C.D., Guan, X., MacLusky, N.J., Hovath, T.L., Diano, S., Singh, M., Connolly, E.S., Nethrapalli, I.S., and Tinnikov, A.A. (2002) ER-X: a novel, plasma membrana-associated, putative estrogen receptor that is regulated during developmentand alter ischemic brain injury. J. Neurosci., 22, 8391-8401.
57. Marin, R., Diaz, M., Alonso, R., Sanz, A., Arévalo, M.A., and Garcia-Segura, L.M. (2009) Role of estrogen receptor α in membrane-initiated signaling in neural cells: interaction with IGF-1 receptor. J. Steroid Biochem. Mol. Biol., 114, 2-7.
58. Marin, R., Ramirez, C.M., Morales, A., Gonzalez, M., Alonso, R., and Diaz, M. (2008) Modulation of Aβ-induced neurotoxicity by estrogen receptor alpha and other associated proteins in lipid rafts. Steroids, 73, 992-996.
59. Garcia-Segura, L.M., Diz-Chaves, Y., Perez-Martin, M., and Darnaudéry, M. (2007) Estradiol, insulin-like growth factor-1 and brain aging. Psychoneuroendocrinology, 32, 557-561.
60. Buettner, R., Papoutsoglou, G., Scemes, E., Spray, D.C., and Dermietzel, R. (2000) Evidence for secretory pathway localization of a voltage-dependent anion channel isoform. Proc. Natl. Acad. Sci. USA, 97, 3201-3206.
61. Ishunina, T.A. and Swaab, D.F. (2003) Increased neuronal metabolic activity and estrogen receptors in the vertical limb of the diagonal band of Broca in Alzheimer's disease: relation to sex and aging. Exp. Neurol., 183, 159-172.
62. Hestiantoro, A. and Swaab, D.F. (2004) Changes in estrogen receptor-α and -β in the infundibular nucleus of the human hypothalamus are related to the occurrence of Alzheimer's disease neuropathology. J. Neurosci. Res., 60, 321-327.
63. Sherwin, B.B. and Henry, J.F. (2008) Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front. Neuroendocrinol., 29, 88-113.
64. Correia, S.C., Santos, R.X., Cardoso, S., Carvalho, C., Santos, M.S., Oliveira, C.T., and Moreira, P.I. (2010) Effects of estrogen in the brain: is it a neuroprotective agent in Alzheimer's disease? Curr. Aging Sci., 3 (2), 113-126.
65. Bi, R., Broutman, G., Roy, M.R., Thompson, R.F., and Baudry, M. (2000) The tyrosine kinase and mitogenactivated protein kinase pathways mediate multiple effects of estrogen in hippocampus. Proc. Natl. Acad. Sci. USA, 97, 3602-3607.
66. Manthey, D., Heck, S., Engert, S., and Behl, C. (2001) Estrogen induces a rapid secretion of amyloid β precursor protein via the mitogen-activated protein kinase pathway. Eur. J. Biochem., 268, 4285-4291.
67. Fitzpatrick, J.L., Mize, A.L., Wade, C.B., Harris, J.A., Shapiro, R.A., and Dorsa, D.M. (2002) Estrogen-mediated neuroprotection against β-amyloid toxicity requires expression of estrogen receptor α or β and activation of the MAPK pathway. J. Neurochem., 82, 674-682.
68. 1-40-induced toxicity in septal-derived cholinergic SN56 cells. J. Neurochem., 85, 1180-1189.
69. Singer, C.A., Figueroa-Masot, X.A., Batchelor, R.H., and Dorsa, D.M. (1999) The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J. Neurosci., 19, 2455-2463.
70. Bryant, D.N., Sheldahl, L.C., Marriot, L.K., Shapiro, R.A., and Dorsa, D.M. (2006) Multiple pathways transmit neuroprotective effects of gonadal steroids. Endocrine, 29 (2), 199-207.
71. Zhang, L., Rubinow, D.R., Xaing, G., Li, B.S., Chang, Y.H., Maric, D., Marker, J.L., and Ma, W. (2001) Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt. Neuroreport, 12, 1919-1923.
72. Zhao, L., Yao, J., Mao, Z., Cheng, S., Wang, Y., and Brinton, R.D. (2010) 17beta-estradiol regulates insulindegrading enzyme expression via an ERbeta/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention. Neurobiol. Aging, doi: 10.1016/j.neurobiolaging.2009.12.010.
73. Chiang, H.Ch., Wang, L., Xie, Z., Yau, A., and Zhong, Y.I. (2010) PI3 kinase signaling is involved in Aβ-induced memory loss in Drosophila. Proc. Natl. Acad. Sci. USA, 107 (15), 7060-7065.
74. Takashima, A. (2006) GSK-3 is essential in the pathogenesis of Alzheimer's disease. J. Alzheimers Dis., 9 (3), 309-317.
75. Goodenough, S., Schleusner, D., Pietrzik, C., Skutella, T., and Behl, C. (2005) Glycogen synthase kinase 3β links neuroprotection by 17b-estradiol to key Alzheimer processes. Neuroscience, 132, 581-589.
76. Tsujimoto, Y. and Shimizu, S. (2007) Role of the mitochondrial membrane permeability transition in cell death. Apoptosis, 12, 835-840.
77. Thinnes, F.P., Gota, H., Kayser, H., Benz, R., Schmidt, W.E., Kratzin, H.D., and Hilschmann, N. (1989) Identification of human porins. I. Purification of a porin from human B-lymphocytes (Porin 31HL) and the topochemical proof of its expression on the plasmalemma of the progenitor cells. Biol. Chem. Hoppe Seyler, 370, 1253-1264.
78. De Pinto, V., Messina, A., Lane, D.J.R., and Lawen, A. (2010) Voltage-dependent anion-selective channel (VDAC) in the plasma membrane. FEBS Lett., 584 (9), 1793-1799.
79. Bahamonde, M.I. and Valverde, M.A. (2003) Voltage-dependent anion channel localizes to the plasma membrane and peripheral but not perinuclear mitochondria. Pflugers Arch., 446, 309-313.
80. Elinder, F., Akanda, N., Tofighi, R., Shimizu, S., Tsujimoto, Y., Orrenius, S., and Ceccatelli, S. (2005) Opening of plasma membrane voltage-dependent anion channels (VDAC) precedes caspase activation in neuronal apoptosis induced by toxic stimuli. Cell Death Differ., 12, 1134-1140.
81. Bàthori, G., Parolini, I., Tombola, F., Szabò, I., Messina, A., Oliva, M. et al. (1999) Porin is present in the plasma membrane where it is concentrated in caveolae and caveolae-related domains. J. Biol. Chem., 274, 29607-29612.
82. Okada, S.F., O'Neal, W.K., Huang, P., Nicholas, R.A., Ostrowski, L.E., Craigen, W.J., Lazarowski, E.R., and Boucher, R.C. (2004) Voltage-dependent anion channel-1 (VDAC-1) contributes to ATP release and cell volume regulation in murine cells. J. Gen. Physiol., 124, 513-526.
83. Thinnes, F.P. (2009) Neuroendocrine differentiation of LNCaP cell suggests: VDAC in the cell membrane is involved in the extrinsic apoptotic pathway. Mol. Genet. Metab., 97, 241-243.
84. Akanda, N., Tofighi, R., Brask, J., Tamm, C., Elinder, F., and Ceccatelli, S. (2008) Voltage-dependent anion channels (VDAC) in the plasma membrane play a critical role in apoptosis in differentiated hippocampal neurons but not in neural stem cells. Cell Cycle, 7, 3225-3234.
85. Ferrer, I. (2009) Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease. J. Bioenerg. Biomembr., 41, 425-431.
86. Kakio, A., Nishimoto, S., Kozutsumi, Y., and Matsuzaki, K. (2003) Formation of a membrane-active form of amyloid b-protein in raft-like model membranes. Biochem. Biophys. Res. Commun., 303, 514-518.
87. Yamamoto, N., Hirabayashi, Y., Amari, M., Yamaguchi, H., Romanov, G., Van Nostrand, W.E., and Yanagisawa, K. (2005) Assembly of hereditary amyloidbeta protein variants in the presence of favorable gangliosides. FEBS Lett., 579 (10), 2185-2190.
88. Zampagni, M., Evangelisti, E., Cascella, R., Liguri, G., Becatti, M., Pensalfini, A. et al. (2010) Lipid rafts are primary mediators of amyloid oxidative attack on plasma membrane. J. Mol. Med., 88, 597-608.
89. Pollard, H.B., Rojas, E., and Arispe, N. (1993) A new hypothesis for the mechanism of amyloid toxicity, based on the calcium channel activity of amyloid beta protein (A beta P) in phospholipid bilayer membranas. Ann. N. Y. Acad. Sci., 695, 165-168.
90. Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., and Malinow, R. (2006) AMPAR removal underlies Aβ-induced synaptic depression and dendritic spine loss. Neuron, 52, 831-843.
91. Liu, S.J., Gasperini, R., Foa, L., and Small, D.H. (2010) Amyloid-β decreases cellsurface AMPA receptors by increasing intracellular calcium and phosphorylation of GluR2. J. Alzheimer's Dis., 21, doi: 10.3233/JAD-2010-091654.
92. Parameshwaran, K., Dhanasekaran, M., and Suppiramaniam, V. (2008) Amyloid beta peptides and glutamatergic synaptic dysregulation. Exp. Neurol., 210, 7-13.
93. - channels by triphenylethylene antioestrogens in C1300 mouse neuroblastoma cells. J. Physiol., 536, 79-88.
94. Tagaki-Morishita, Y., Yamada, N., Sugihara, A., Iwasaki, T., Tsujimura, T., and Terada, N. (2003) Mouse uterine epithelial apoptosis is associated with the expression of mitochondrial voltagedependent anion channels, release of cytochrome c from mitochondria, and the ratio of Bax to Bcl-2 or Bcl-X. Biol. Reprod., 68, 1178-1184.
95. Yoo, B.C., Fountoulakis, M., Cairns, N., and Lubec, G. (2001) Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome. Electrophoresis, 22, 172-179.
96. Sultana, R., Poon, H.F., Cai, J., Pierce, W.M., Merchant, M., Klein, J.B. et al. (2006) Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol. Dis., 22, 76-87.
97. Michel, V. and Bakovic, M. (2007) Lipid rafts in health and disease. Biol. Cell, 99, 129-140.
98. Vetrivel, K.S. and Thinakaran, G. (2010) Membrane rafts in Alzheimer's disease beta-amyloid production. Biochim. Biophys. Acta, 1801, 860-867.
99. Molander-Melin, M., Blennow, M., Bogdanovic, N., Dellheden, B., Mansson, J.E., and Fredman, P. (2005) Structural membrane alterations in Alzheimer brains found to be associated with regional disease development, increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergentresistant membrane domains. J. Neurochem., 92, 171-182.
100. Young, G. and Conquer, J. (2005) Omega-3 fatty acids and neuropsychiatric disorders. Reprod. Nutr. Dev., 45, 1-28.
101. Lane, R.M. and Farlow, M.R. (2005) Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease. J. Lipid Res., 46, 949-968.
102. Martin, V., Fabelo, N., Santpere, G., Puig, B., Marin, R., Ferrer, I., and Diaz, M. (2010) Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex. J. Alzheimer's Dis., 19, 489-502.
103. Plourde, M., Fortier, M., Vandal, M., Tremblay-Mercier, J., Freemantle, E., Bégin, M., Pifferi, F., and Cunnane, S.C. (2007) Unresolved issues in the link between docosahexanoic acid and Alzheimer's disease. Prostaglandins Leukot. Essent. Fatty Acids, 77, 301-308.
104. Garcia-Ovejero, D., Veiga, S., Garcia-Segura, L.M., and DonCarlos, L.L. (2002) Glial expression of estrogen and androgen receptors after rat brain injury. J. Comp. Neurol., 450, 256-271.